Cx-602

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCx-602
Drug Alias Nameallogeneic adipose-derived mesenchymal stem cells (TiGenix/Fundacion La Paz)allogeneic adipose-derived mesenchymal stem cells (Cellerix/Fundacion La Paz)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellerix Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundacion Para La Investigacion Biomedica Del Hospital Universitario La PazCellerix Sa
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A